{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-22-013842","form_type":"8-K","ticker":"MLAB","cik":"0000724004","company_name":"MESA LABORATORIES INC /CO/","filed_at":"2022-05-31T23:59:59+00:00","discovered_at":"2026-05-14T18:04:03.482560+00:00","generated_at":"2026-06-25T06:03:26.341084+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Mesa Labs reports Q4 GAAP operating loss of $110k; adjusted op income ex-unusual items up 31%","bullets":["GAAP operating loss of $110k vs income of $4.3M a year ago; net loss $1.78M (-$0.34 diluted EPS).","Non-GAAP adjusted operating income (AOI) rose 11% to $11.65M; AOI ex-unusual items up 31% to $13.57M.","Total revenues grew 55% in Q4 to $58.9M, organic +12%; FY revenues up 38% to $184.3M, organic +13%.","Clinical Genomics segment revenue $16.4M including $1.4M COVID; ex-COVID below plan, China lockdowns expected to impact Q1.","FY23 guidance cautious: lower organic growth expected due to inflation, war in Europe, and Asia pandemic resurgence."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-22-013842","json":"https://secwatch.observer/filing/0001437749-22-013842.json","markdown":"https://secwatch.observer/filing/0001437749-22-013842.md","text":"https://secwatch.observer/filing/0001437749-22-013842.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/724004/000143774922013842/0001437749-22-013842-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/724004/000143774922013842/mlab20220528_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T06:03:26.341084+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}